...
首页> 外文期刊>Journal of Neuropathology and Experimental Neurology: Official Journal of the American Association of Neuropathologists, Inc >Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature
【24h】

Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature

机译:缺乏其他恶性组织学特征的具有横纹肌样特征的脑膜瘤:44例病例研究并文献复习

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The behavior of rhabdoid meningiomas otherwise lacking malignant features remains unknown as most of the originally reported aggressive cases showed anaplastic histologic features independently of rhabdoid phenotype. We studied 44 patients with rhabdoid meningiomas lacking anaplastic features. Median age at diagnosis was 48.6 years (range 10-79). Location was supratentorial in 28 (63.6%), skull base in 15 (34.1%), and spinal in 1 (2.3%). Tumor grade was otherwise World Health Organization grade I (n = 22, 50%) or II (n = 22, 50%). Rhabdoid cells represented <20% of the tumor in 12 cases (27.3%), 20% to 50% in 18 (40.9%), and > 50% in 14 (31.8%). Median clinical follow-up, available for 38 patients, was 5.0 years (range 0.17-14.2). Recurrence occurred in 9 patients (5-year recurrence-free survival, 73.7%) with a significantly higher risk in subtotally resected tumors (p = 0.043). Rhabdoid cell percentage was not associated with recurrence. Six patients died (4 of disease, 2 of unclear causes); 5-year overall survival was 86.7%, a mortality in excess of that expected in grade I-II meningiomas but much lower than originally reported. Review of 50 similar previously reported cases confirmed our findings. We suggest that rhabdoid meningiomas be graded analogously to non-rhabdoid tumors, with caution that some may still behave aggressively and close follow-up is recommended.
机译:缺乏恶性特征的横纹肌瘤脑膜瘤的行为仍然未知,因为大多数最初报道的侵袭性病例显示出与横纹肌瘤表型无关的变性组织学特征。我们研究了44例缺乏间变性特征的横纹肌瘤。诊断时的中位年龄为48.6岁(范围10-79)。幕上位置28处(63.6%),颅底位置15处(34.1%),脊柱位置1处(2.3%)。否则,肿瘤等级为世界卫生组织的I级(n = 22,50%)或II级(n = 22,50%)。横纹肌样细胞在12例中占肿瘤的20%(27.3%),在18例中占20%至50%(40.9%),在14例中占50%以上(31.8%)。可用于38例患者的中位临床随访时间为5.0年(范围0.17-14.2)。 9例患者复发(5年无复发生存率,73.7%),其次全切除肿瘤的风险明显更高(p = 0.043)。横纹肌细胞百分比与复发无关。 6例患者死亡(4例疾病,2例原因不明); 5年总生存率为86.7%,死亡率超过I-II级脑膜瘤的预期死亡率,但远低于最初报道的水平。对50例以前报道过的类似病例的回顾证实了我们的发现。我们建议将类风湿性脑膜瘤的分级与非类风湿性腺瘤相似,并应谨慎行事,建议密切随访。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号